GLOBAL BIO-CHEM (00809) and Hefei Hemei will establish and collaborate to operate a synthetic biology pilot platform at the Xinglong Mountain production base.

GLOBAL BIO-CHEM (00809) announced that on May 20, 2025, the group participated in the launch ceremony of the Changchun Economic and Technological Development Zone Synthetic Biology Industry Innovation and Development Pilot Area, jointly organized by the Changchun Economic and Technological Development Zone Management Committee and Changchun City Equity Investment Fund Management Co., Ltd. At the conference, the company's wholly-owned subsidiary, Changchun Hongcheng Biochemical Material Technology Development Co., Ltd. (Hongcheng Bio Technology), signed a strategic cooperation framework agreement with Hefei Han Chen Biological Technology Co., Ltd. established in the People's Republic of China (Hefei Han Chen). On May 20, 2025, the group participated in the conference, where attendees included provincial and municipal government agencies, the Chinese Academy of Sciences, domestic universities, synthetic biology companies, investment companies, and fund management entities, reaching strategic cooperation agreements and signing multiple framework agreements to establish a synthetic biology industry innovation and development pilot area in Changchun. The main focus of the conference was the signing ceremony of the Changxing Oasis Sub-Fund, established with an initial amount of RMB 50 million by its fund partners, focusing on the application of synthetic biology technology in biomanufacturing, agricultural technology, and green energy, and promoting cooperation with large-scale, high-tech, and high-growth enterprises in China to help Changchun City build a highland of synthetic biology technology industry in Northeast China and promote high-quality industrial development. As part of the conference agenda, Hongcheng Bio Technology and Hefei Han Chen signed a strategic cooperation framework agreement to leverage their respective strengths in the field of synthetic biology, focusing on key industrial applications in Jilin Province and supporting the development of the province's biomanufacturing industry. Specifically, the strategic cooperation aims to combine the group's experience in technology scaling, process optimization, production process design, and cost control with Hefei Han Chen's advantages in synthetic biology (including gene design, strain construction, and metabolic pathway optimization) to jointly promote the industrial application of synthetic biology technology in the amino acid field, thereby enhancing the market competitiveness of both parties. According to the current strategic cooperation plan, the group and Hefei Han Chen will use the research center and pilot facilities at the group's Xinglong Mountain production base to establish and operate a synthetic biology pilot platform. The R&D facilities at the Xinglong Mountain production base include approximately 10,000 square meters of factory and workshop space, along with four research and development centers for biochemical, biological fermentation, food, and animal protection. It also has a biorefinery product pilot workshop equipped with seven biotechnological pilot facilities. Following the signing of the strategic cooperation framework agreement, the inauguration ceremony of the pilot platform was successfully held during the conference, marking the completion of the "last mile" bridge in the process of transforming technological achievements into industrial achievements, and assisting in the industrial breakthrough of biobased chemicals, medical materials, and other related fields. As of the date of this announcement, the group's Xinglong Mountain production base is still temporarily suspended.